Variability in measuring the Ki-67 labeling index in patients with breast cancer

Clinical Breast Cancer

Volumn 15, Issue 1, 2015, Pages e35-e39

  Yamamoto, Shinya ^a   Chishima, Takashi ^a   Mastubara, Yuka ^a   Adachi, Shouko ^a   Harada, Fumi ^a   Toda, Youko ^a   Arioka, Hitoshi ^a   Hasegawa, Naoki ^a   Kakuta, Yukio ^a   Sakamaki, Kentaro ^b  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Breast cancer; Hot spot; Ki 67; Luminal type; Varability

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LUMINAL TYPE BREAST CANCER; MAJOR CLINICAL STUDY; MEASUREMENT; PARTIAL MASTECTOMY; AGED; BREAST NEOPLASMS; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; PROCEDURES; STAINING; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; OBSERVER VARIATION; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84920468019     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2014.09.005     Document Type: Article

References (20)

1. A. Goldhirsch, W.C. Wood, and A.S. Coates Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
2. M. Dowsett, T.O. Nielsen, and R. A'Hern Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group J Natl Cancer Inst 103 2011 1656 1664
3. G. Key, M.H. Becker, and B. Baron New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope Lab Invest 68 1993 629 636
4. A. Pich, R. Ponti, and G. Valente MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas J Clin Pathol 47 1994 18 22
5. Tumours of the Breast and Female Genital Organs 2003 Oxford University Press Oxford
6. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
7. J. Gerdes, U. Schwab, H. Lemke, and H. Stein Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation Int J Cancer 31 1983 13 20
8. N. Bouzubar, K.J. Walker, and K. Griffiths Ki67 immunostaining in primary breast cancer: pathological and clinical associations Br J Cancer 59 1989 943 947
9. E. de Azambuja, F. Cardoso, and G. de Castro Jr. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 2007 1504 1513
10. G. Bonadonna, P. Valagussa, A. Moliterni, M. Zambetti, and C. Brambilla Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up N Engl J Med 332 1995 901 906
11. T. de Oliveira Gozzo, A.M.B. Moysés, P.R. da Silva, and A.M. de Almeida [Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy] Rev Gaucha Enferm 34 2013 110 116
12. A.C. Klimowicz, P. Bose, and S.C. Nakoneshny Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma Eur J Cancer 48 2012 2166 2174
13. P.P. Goodell, A.M. Krasinskas, J.M. Davison, and D.J. Hartman Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors Am J Clin Pathol 137 2012 576 582
14. Q. Romero, P.O. Bendahl, and M. Klintman Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies BMC Cancer 11 2011 341
15. C.W. Ong, L.G. Kim, and H.H. Kong Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantage Histopathology 56 2010 523 529
16. S. Gokhale, D. Rosen, and N. Sneige Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma Appl Immunohistochem Mol Morphol 15 2007 451 455
17. F. Demichelis, M. Barbareschi, P. Dalla Palma, and S. Forti The virtual case: a new method to completely digitize cytological and histological slides Virchows Arch 441 2002 159 164
18. S. Fasanella, E. Leonardi, and C. Cantaloni Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies Diagn Pathol 6 suppl 1 2011 S7
19. S. Paik, S. Shak, and G. Tang A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826
20. S. Paik, G. Tang, and S. Shak Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 2006 3726 3734